Leucine promotes tumor evasion by inducing leucine-tRNA-synthetase-2 expressing B cell (LARS B) which inhibits mitochondrial NAD + regeneration and oxidative metabolism, leading to increased TGF-β1 production. The gene discussed is TGFB1; the disease is neoplasm.